Join Growin Stock Community!
Beta
Back to PFE.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Operating ROA
  • ROS
  • Profit Margin
operating-roa-chart

PFE Operating ROA

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, Pfizer's ROE stands at 2.98%, ROA at 1.29%, and ROIC at 1.94%, reflecting a modest positive performance across all metrics following a challenging Q4'25 where ROE and ROA dipped into negative territory at -1.91% and -0.79%, respectively, while ROIC data is unavailable for that period. Over the period from Q2'23 to Q1'26, the metrics exhibit volatility with an overall stabilizing trend toward positive values; ROE and ROA fluctuated between highs of 4.84% (ROE in Q3'24) and lows of -3.78% (ROE in Q4'23), showing recovery patterns in 2024 and 2025 except for the Q4'25 downturn, whereas ROIC experienced a sharp anomaly at -132.68% in Q4'24 amid otherwise consistent single-digit positives, with data gaps in Q2'25 and Q4'25 limiting full trend visibility.